| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.34 | 5e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |